Výsledky vyhľadávania - "Drug Monitoring (mesh)"
-
1
Autori:
Zdroj: Clinical and Translational Science. 18(10)
Predmety: 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), Rare Diseases (rcdc), Networking and Information Technology R&D (NITRD) (rcdc), Orphan Drug (rcdc), Machine Learning and Artificial Intelligence (rcdc), 5.1 Pharmaceuticals (hrcs-rac), Generic health relevance (hrcs-hc), Humans (mesh), Anticonvulsants (mesh), Drug Monitoring (mesh), Models, Biological (mesh), Artificial Intelligence (mesh), Prohibitins (mesh), Male (mesh), Epilepsy (mesh), Female (mesh), Adult (mesh), Middle Aged (mesh), Valproic Acid (mesh), Phenytoin (mesh), Phenobarbital (mesh), Carbamazepine (mesh), Young Adult (mesh), artificial intelligence, population pharmacokinetic model, predictive performance, Humans (mesh), Epilepsy (mesh), Valproic Acid (mesh), Phenytoin (mesh), Phenobarbital (mesh), Carbamazepine (mesh), Anticonvulsants (mesh), Drug Monitoring (mesh), Models, Biological (mesh), Artificial Intelligence (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Young Adult (mesh), Prohibitins (mesh), artificial intelligence, population pharmacokinetic model, predictive performance, Humans (mesh), Anticonvulsants (mesh), Drug Monitoring (mesh), Models, Biological (mesh), Artificial Intelligence (mesh), Prohibitins (mesh), Male (mesh), Epilepsy (mesh), Female (mesh), Adult (mesh), Middle Aged (mesh), Valproic Acid (mesh), Phenytoin (mesh), Phenobarbital (mesh), Carbamazepine (mesh), Young Adult (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), 1112 Oncology and Carcinogenesis (for), 1199 Other Medical and Health Sciences (for), General Clinical Medicine (science-metrix), 3201 Cardiovascular medicine and haematology (for-2020), 3214 Pharmacology and pharmaceutical sciences (for-2020)
Popis súboru: application/pdf
-
2
Autori: a ďalší
Zdroj: Clinical Pharmacokinetics. 62(3)
Predmety: 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Emerging Infectious Diseases (rcdc), Prevention (rcdc), Rare Diseases (rcdc), Women's Health (rcdc), Tuberculosis (rcdc), Orphan Drug (rcdc), Infectious Diseases (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 3 Good Health and Well Being (sdg), Humans (mesh), Drug Monitoring (mesh), Antitubercular Agents (mesh), Tuberculosis (mesh), Humans (mesh), Tuberculosis (mesh), Antitubercular Agents (mesh), Drug Monitoring (mesh), Humans (mesh), Drug Monitoring (mesh), Antitubercular Agents (mesh), Tuberculosis (mesh), 1115 Pharmacology and Pharmaceutical Sciences (for), Pharmacology & Pharmacy (science-metrix), 3214 Pharmacology and pharmaceutical sciences (for-2020)
Popis súboru: application/pdf
-
3
Autori: a ďalší
Zdroj: BMC Infectious Diseases. 21(1)
Predmety: 3207 Medical Microbiology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Emerging Infectious Diseases (rcdc), Sexually Transmitted Infections (rcdc), Tuberculosis (rcdc), Antimicrobial Resistance (rcdc), Biodefense (rcdc), Rare Diseases (rcdc), HIV/AIDS (rcdc), Orphan Drug (rcdc), Clinical Research (rcdc), Infectious Diseases (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 6.1 Pharmaceuticals (hrcs-rac), Infection (hrcs-hc), 3 Good Health and Well Being (sdg), Adult (mesh), Antitubercular Agents (mesh), Chromatography, Liquid (mesh), Drug Monitoring (mesh), Female (mesh), Hair (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Mycobacterium tuberculosis (mesh), Rifampin (mesh), Sensitivity and Specificity (mesh), Tandem Mass Spectrometry (mesh), Tuberculosis (mesh), Tuberculosis, Multidrug-Resistant (mesh), LC-MS, MS, Hair, Multidrug-resistant tuberculosis, Hair (mesh), Humans (mesh), Mycobacterium tuberculosis (mesh), Tuberculosis (mesh), Tuberculosis, Multidrug-Resistant (mesh), Rifampin (mesh), Antitubercular Agents (mesh), Drug Monitoring (mesh), Chromatography, Liquid (mesh), Sensitivity and Specificity (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Tandem Mass Spectrometry (mesh), Hair, LC-MS/MS, Multidrug-resistant tuberculosis, Adult (mesh), Antitubercular Agents (mesh), Chromatography, Liquid (mesh), Drug Monitoring (mesh), Female (mesh), Hair (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Mycobacterium tuberculosis (mesh), Rifampin (mesh), Sensitivity and Specificity (mesh), Tandem Mass Spectrometry (mesh), Tuberculosis (mesh), Tuberculosis, Multidrug-Resistant (mesh), 0605 Microbiology (for), 1103 Clinical Sciences (for), 1108 Medical Microbiology (for), Microbiology (science-metrix), 3202 Clinical sciences (for-2020), 3207 Medical microbiology (for-2020), 4206 Public health (for-2020)
Popis súboru: application/pdf
-
4
Autori: a ďalší
Zdroj: Journal of the American Geriatrics Society. 69(2)
Predmety: 4203 Health Services and Systems (for-2020), 42 Health Sciences (for-2020), Diabetes (rcdc), Aging (rcdc), Metabolic and endocrine (hrcs-hc), Aged (mesh), Blood Glucose (mesh), Diabetes Mellitus, Type 2 (mesh), Drug Monitoring (mesh), Female (mesh), Guideline Adherence (mesh), Homes for the Aged (mesh), Humans (mesh), Hypoglycemia (mesh), Hypoglycemic Agents (mesh), Male (mesh), Nursing Homes (mesh), Practice Guidelines as Topic (mesh), Procedures and Techniques Utilization (mesh), Risk Assessment (mesh), United States (mesh), United States Department of Veterans Affairs (mesh), Unnecessary Procedures (mesh), fingerstick, diabetes mellitus, type II, glucose monitoring, Veterans Affairs nursing home, glucose-lowering medication, Humans (mesh), Diabetes Mellitus, Type 2 (mesh), Hypoglycemia (mesh), Blood Glucose (mesh), Hypoglycemic Agents (mesh), Drug Monitoring (mesh), Risk Assessment (mesh), United States Department of Veterans Affairs (mesh), Aged (mesh), Homes for the Aged (mesh), Nursing Homes (mesh), Unnecessary Procedures (mesh), Guideline Adherence (mesh), United States (mesh), Female (mesh), Male (mesh), Practice Guidelines as Topic (mesh), Procedures and Techniques Utilization (mesh), Veterans Affairs nursing home, diabetes mellitus, type II, fingerstick, glucose monitoring, glucose-lowering medication, Aged (mesh), Blood Glucose (mesh), Diabetes Mellitus, Type 2 (mesh), Drug Monitoring (mesh), Female (mesh), Guideline Adherence (mesh), Homes for the Aged (mesh), Humans (mesh), Hypoglycemia (mesh), Hypoglycemic Agents (mesh), Male (mesh), Nursing Homes (mesh), Practice Guidelines as Topic (mesh), Procedures and Techniques Utilization (mesh), Risk Assessment (mesh), United States (mesh), United States Department of Veterans Affairs (mesh), Unnecessary Procedures (mesh), 11 Medical and Health Sciences (for), Geriatrics (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020), 52 Psychology (for-2020)
Popis súboru: application/pdf
-
5
Autori: a ďalší
Zdroj: PLOS ONE. 16(3)
Predmety: 3401 Analytical Chemistry (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 34 Chemical Sciences (for-2020), Infectious Diseases (rcdc), 3 Good Health and Well Being (sdg), Anti-Bacterial Agents (mesh), Antimalarials (mesh), Azithromycin (mesh), Blood Specimen Collection (mesh), Chloroquine (mesh), Chromatography, High Pressure Liquid (mesh), Drug Monitoring (mesh), Edetic Acid (mesh), Humans (mesh), Hydroxychloroquine (mesh), Limit of Detection (mesh), Tandem Mass Spectrometry (mesh), Humans (mesh), Edetic Acid (mesh), Azithromycin (mesh), Chloroquine (mesh), Hydroxychloroquine (mesh), Anti-Bacterial Agents (mesh), Antimalarials (mesh), Drug Monitoring (mesh), Blood Specimen Collection (mesh), Chromatography, High Pressure Liquid (mesh), Tandem Mass Spectrometry (mesh), Limit of Detection (mesh), Anti-Bacterial Agents (mesh), Antimalarials (mesh), Azithromycin (mesh), Blood Specimen Collection (mesh), Chloroquine (mesh), Chromatography, High Pressure Liquid (mesh), Drug Monitoring (mesh), Edetic Acid (mesh), Humans (mesh), Hydroxychloroquine (mesh), Limit of Detection (mesh), Tandem Mass Spectrometry (mesh), General Science & Technology (science-metrix)
Popis súboru: application/pdf
-
6
Autori: a ďalší
Zdroj: Intensive Care Med
Predmety: Adult, Piperacillin, Critical Care, 615 Pharmazie, Original, Critical Illness, Humans, Bayes Theorem, Drug Monitoring, ddc:615, Anti-Bacterial Agents [MeSH], Adult [MeSH], Humans [MeSH], Intensive care medicine, Pharmacokinetics/pharmacodynamics, Drug Monitoring [MeSH], Bayes Theorem [MeSH], Critical Care [MeSH], Critical Illness/therapy [MeSH], Model-informed precision dosing, Therapeutic drug monitoring, Piperacillin [MeSH], 3. Good health, Anti-Bacterial Agents
Popis súboru: application/pdf
-
7
Autori:
Zdroj: Nervenarzt
Predmety: Female [MeSH], Depressive Disorder/drug therapy [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Drug Monitoring [MeSH], Middle Aged [MeSH], Male [MeSH], Kurzbeiträge, Germany [MeSH], Length of Stay [MeSH], Patient Admission [MeSH], Antidepressive Agents/therapeutic use [MeSH]
Prístupová URL adresa: https://repository.publisso.de/resource/frl:6516673
-
8
Autori: a ďalší
Zdroj: Journal of Telemedicine and Telecare. 26(6)
Predmety: 4203 Health Services and Systems (for-2020), 4206 Public Health (for-2020), 42 Health Sciences (for-2020), Clinical Research (rcdc), Autoimmune Disease (rcdc), Diabetes (rcdc), Clinical Trials and Supportive Activities (rcdc), Pediatric (rcdc), Prevention (rcdc), 7.1 Individual care needs (hrcs-rac), Metabolic and endocrine (hrcs-hc), Blood Glucose (mesh), Child (mesh), Diabetes Mellitus, Type 1 (mesh), Drug Monitoring (mesh), Female (mesh), Glycated Hemoglobin (mesh), Home Care Services, Hospital-Based (mesh), Humans (mesh), Male (mesh), Remote Consultation (mesh), Surveys and Questionnaires (mesh), Telephone (mesh), Videoconferencing (mesh), Telemedicine, remote consultation, home telecare, Humans (mesh), Diabetes Mellitus, Type 1 (mesh), Blood Glucose (mesh), Drug Monitoring (mesh), Remote Consultation (mesh), Telephone (mesh), Videoconferencing (mesh), Child (mesh), Home Care Services, Hospital-Based (mesh), Female (mesh), Male (mesh), Surveys and Questionnaires (mesh), Glycated Hemoglobin (mesh), Telemedicine, home telecare, remote consultation, Blood Glucose (mesh), Child (mesh), Diabetes Mellitus, Type 1 (mesh), Drug Monitoring (mesh), Female (mesh), Glycated Hemoglobin (mesh), Home Care Services, Hospital-Based (mesh), Humans (mesh), Male (mesh), Remote Consultation (mesh), Surveys and Questionnaires (mesh), Telephone (mesh), Videoconferencing (mesh), 0806 Information Systems (for), 0903 Biomedical Engineering (for), 1117 Public Health and Health Services (for), Medical Informatics (science-metrix), 4203 Health services and systems (for-2020), 4206 Public health (for-2020)
Popis súboru: application/pdf
-
9
Autori: a ďalší
Zdroj: JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(2)
Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Clinical Research (rcdc), Infection (hrcs-hc), 3 Good Health and Well Being (sdg), Adult (mesh), Anti-HIV Agents (mesh), Antibodies (mesh), Drug Combinations (mesh), Drug Monitoring (mesh), Emtricitabine (mesh), Enzyme-Linked Immunosorbent Assay (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Kenya (mesh), Laboratories (mesh), Male (mesh), Patient Compliance (mesh), Point-of-Care Testing (mesh), Sensitivity and Specificity (mesh), Tenofovir (mesh), Uganda (mesh), pre-exposure prophylaxis, point-of-care, adherence, real-time, antiretroviral therapy, Partners PrEP Study Team, Humans (mesh), HIV Infections (mesh), Antibodies (mesh), Drug Combinations (mesh), Anti-HIV Agents (mesh), Drug Monitoring (mesh), Enzyme-Linked Immunosorbent Assay (mesh), Sensitivity and Specificity (mesh), Patient Compliance (mesh), Adult (mesh), Laboratories (mesh), Kenya (mesh), Uganda (mesh), Female (mesh), Male (mesh), Tenofovir (mesh), Emtricitabine (mesh), Point-of-Care Testing (mesh), Adult (mesh), Anti-HIV Agents (mesh), Antibodies (mesh), Drug Combinations (mesh), Drug Monitoring (mesh), Emtricitabine (mesh), Enzyme-Linked Immunosorbent Assay (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Kenya (mesh), Laboratories (mesh), Male (mesh), Patient Compliance (mesh), Point-of-Care Testing (mesh), Sensitivity and Specificity (mesh), Tenofovir (mesh), Uganda (mesh), 1103 Clinical Sciences (for), 1117 Public Health and Health Services (for), Virology (science-metrix), 3202 Clinical sciences (for-2020), 4202 Epidemiology (for-2020), 4206 Public health (for-2020)
Popis súboru: application/pdf
-
10
Autori: a ďalší
Zdroj: Journal of the International AIDS Society. 23(3)
Predmety: 3207 Medical Microbiology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Sexually Transmitted Infections (rcdc), Prevention (rcdc), Machine Learning and Artificial Intelligence (rcdc), Clinical Research (rcdc), Bioengineering (rcdc), Infectious Diseases (rcdc), HIV/AIDS (rcdc), Infection (hrcs-hc), 3 Good Health and Well Being (sdg), Adult (mesh), Anti-HIV Agents (mesh), CD4 Lymphocyte Count (mesh), Cohort Studies (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), HIV-1 (mesh), Humans (mesh), Longitudinal Studies (mesh), Machine Learning (mesh), Male (mesh), Medication Adherence (mesh), Uganda (mesh), Viral Load (mesh), Viremia (mesh), adherence, machine learning, real-time adherence monitoring, viral load monitoring, virologic failure, viraemia, Humans (mesh), HIV-1 (mesh), Viremia (mesh), HIV Infections (mesh), Anti-HIV Agents (mesh), Drug Monitoring (mesh), CD4 Lymphocyte Count (mesh), Viral Load (mesh), Cohort Studies (mesh), Longitudinal Studies (mesh), Adult (mesh), Uganda (mesh), Female (mesh), Male (mesh), Medication Adherence (mesh), Machine Learning (mesh), adherence, machine learning, real-time adherence monitoring, viraemia, viral load monitoring, virologic failure, Adult (mesh), Anti-HIV Agents (mesh), CD4 Lymphocyte Count (mesh), Cohort Studies (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), HIV-1 (mesh), Humans (mesh), Longitudinal Studies (mesh), Machine Learning (mesh), Male (mesh), Medication Adherence (mesh), Uganda (mesh), Viral Load (mesh), Viremia (mesh), 1103 Clinical Sciences (for), 1117 Public Health and Health Services (for), 1199 Other Medical and Health Sciences (for), 3202 Clinical sciences (for-2020), 4202 Epidemiology (for-2020), 4206 Public health (for-2020)
Popis súboru: application/pdf
-
11
Autori: a ďalší
Zdroj: Pediatric Blood & Cancer. 66(11)
Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3201 Cardiovascular Medicine and Haematology (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Childhood Leukemia (rcdc), Hematology (rcdc), Rare Diseases (rcdc), Pediatric (rcdc), Regenerative Medicine (rcdc), Pediatric Cancer (rcdc), Clinical Research (rcdc), Genetics (rcdc), Cancer (rcdc), Stem Cell Research (rcdc), Transplantation (rcdc), Orphan Drug (rcdc), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), Cancer (hrcs-hc), Antimetabolites, Antineoplastic (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Child (mesh), Child, Preschool (mesh), Combined Modality Therapy (mesh), DNA, Neoplasm (mesh), Drug Evaluation (mesh), Drug Monitoring (mesh), Female (mesh), Follow-Up Studies (mesh), Genes, Neoplasm (mesh), Graft vs Host Disease (mesh), Hematopoietic Stem Cell Transplantation (mesh), Humans (mesh), Infant (mesh), Leukemia, Myelomonocytic, Juvenile (mesh), Male (mesh), Neoadjuvant Therapy (mesh), Neoplasm Proteins (mesh), Progression-Free Survival (mesh), Recurrence (mesh), Retrospective Studies (mesh), Sequence Analysis, DNA (mesh), Splenectomy (mesh), Transplantation Conditioning (mesh), Tumor Burden (mesh), chemotherapy, JMML, molecular response, outcome, stem cell transplantation, Humans (mesh), Graft vs Host Disease (mesh), Recurrence (mesh), Neoplasm Proteins (mesh), DNA, Neoplasm (mesh), Antimetabolites, Antineoplastic (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Drug Monitoring (mesh), Transplantation Conditioning (mesh), Combined Modality Therapy (mesh), Neoadjuvant Therapy (mesh), Splenectomy (mesh), Hematopoietic Stem Cell Transplantation (mesh), Tumor Burden (mesh), Retrospective Studies (mesh), Follow-Up Studies (mesh), Drug Evaluation (mesh), Sequence Analysis, DNA (mesh), Child (mesh), Child, Preschool (mesh), Infant (mesh), Female (mesh), Male (mesh), Genes, Neoplasm (mesh), Leukemia, Myelomonocytic, Juvenile (mesh), Progression-Free Survival (mesh), JMML, chemotherapy, molecular response, outcome, stem cell transplantation, Antimetabolites, Antineoplastic (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Child (mesh), Child, Preschool (mesh), Combined Modality Therapy (mesh), DNA, Neoplasm (mesh), Drug Evaluation (mesh), Drug Monitoring (mesh), Female (mesh), Follow-Up Studies (mesh), Genes, Neoplasm (mesh), Graft vs Host Disease (mesh), Hematopoietic Stem Cell Transplantation (mesh), Humans (mesh), Infant (mesh), Leukemia, Myelomonocytic, Juvenile (mesh), Male (mesh), Neoadjuvant Therapy (mesh), Neoplasm Proteins (mesh), Progression-Free Survival (mesh), Recurrence (mesh), Retrospective Studies (mesh), Sequence Analysis, DNA (mesh), Splenectomy (mesh), Transplantation Conditioning (mesh), Tumor Burden (mesh), 1103 Clinical Sciences (for), 1112 Oncology and Carcinogenesis (for), 1114 Paediatrics and Reproductive Medicine (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020), 3213 Paediatrics (for-2020)
Popis súboru: application/pdf
-
12
Autori: a ďalší
Zdroj: PLOS Medicine. 16(4)
Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Emerging Infectious Diseases (rcdc), Sexually Transmitted Infections (rcdc), Patient Safety (rcdc), Biodefense (rcdc), Rare Diseases (rcdc), Clinical Research (rcdc), Tuberculosis (rcdc), Infectious Diseases (rcdc), Orphan Drug (rcdc), Antimicrobial Resistance (rcdc), HIV/AIDS (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Infection (hrcs-hc), 3 Good Health and Well Being (sdg), Adolescent (mesh), Antitubercular Agents (mesh), Child (mesh), Child, Preschool (mesh), Dose-Response Relationship, Drug (mesh), Drug Monitoring (mesh), Female (mesh), Humans (mesh), Infant (mesh), Linezolid (mesh), Male (mesh), Prospective Studies (mesh), South Africa (mesh), Treatment Outcome (mesh), Tuberculosis, Multidrug-Resistant (mesh), Humans (mesh), Tuberculosis, Multidrug-Resistant (mesh), Antitubercular Agents (mesh), Drug Monitoring (mesh), Treatment Outcome (mesh), Prospective Studies (mesh), Dose-Response Relationship, Drug (mesh), Adolescent (mesh), Child (mesh), Child, Preschool (mesh), Infant (mesh), South Africa (mesh), Female (mesh), Male (mesh), Linezolid (mesh), Adolescent (mesh), Antitubercular Agents (mesh), Child (mesh), Child, Preschool (mesh), Dose-Response Relationship, Drug (mesh), Drug Monitoring (mesh), Female (mesh), Humans (mesh), Infant (mesh), Linezolid (mesh), Male (mesh), Prospective Studies (mesh), South Africa (mesh), Treatment Outcome (mesh), Tuberculosis, Multidrug-Resistant (mesh), 11 Medical and Health Sciences (for), General & Internal Medicine (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
Popis súboru: application/pdf
-
13
Autori: a ďalší
Zdroj: Antiviral Therapy. 24(2)
Predmety: 3215 Reproductive Medicine (for-2020), 32 Biomedical and Clinical Sciences (for-2020), Infectious Diseases (rcdc), Women's Health (rcdc), Clinical Research (rcdc), Pediatric (rcdc), HIV/AIDS (rcdc), Perinatal Period - Conditions Originating in Perinatal Period (rcdc), Sexually Transmitted Infections (rcdc), Pregnancy (rcdc), Clinical Trials and Supportive Activities (rcdc), Reproductive health and childbirth (hrcs-hc), 3 Good Health and Well Being (sdg), Adolescent (mesh), Adult (mesh), Alkynes (mesh), Antiretroviral Therapy, Highly Active (mesh), Benzoxazines (mesh), Child (mesh), Child, Preschool (mesh), Cyclopropanes (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Infant (mesh), Infant, Newborn (mesh), Pregnancy (mesh), Pregnancy Complications, Infectious (mesh), Reverse Transcriptase Inhibitors (mesh), Treatment Outcome (mesh), Young Adult (mesh), Humans (mesh), Pregnancy Complications, Infectious (mesh), HIV Infections (mesh), Alkynes (mesh), Cyclopropanes (mesh), Benzoxazines (mesh), Reverse Transcriptase Inhibitors (mesh), Drug Monitoring (mesh), Treatment Outcome (mesh), Antiretroviral Therapy, Highly Active (mesh), Pregnancy (mesh), Adolescent (mesh), Adult (mesh), Child (mesh), Child, Preschool (mesh), Infant (mesh), Infant, Newborn (mesh), Female (mesh), Young Adult (mesh), Adolescent (mesh), Adult (mesh), Alkynes (mesh), Antiretroviral Therapy, Highly Active (mesh), Benzoxazines (mesh), Child (mesh), Child, Preschool (mesh), Cyclopropanes (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Infant (mesh), Infant, Newborn (mesh), Pregnancy (mesh), Pregnancy Complications, Infectious (mesh), Reverse Transcriptase Inhibitors (mesh), Treatment Outcome (mesh), Young Adult (mesh), 0605 Microbiology (for), 1103 Clinical Sciences (for), 1108 Medical Microbiology (for), Virology (science-metrix), 3107 Microbiology (for-2020), 3202 Clinical sciences (for-2020), 3207 Medical microbiology (for-2020)
Popis súboru: application/pdf
-
14
Autori:
Zdroj: Intensive Care Med
Predmety: Anti-Infective Agents, Humans, What's New in Intensive Care, Drug Monitoring, Intensive / Critical Care Medicine, Anesthesiology, Pain Medicine, Pediatrics, Pneumology/Respiratory System, Anti-Infective Agents/therapeutic use [MeSH], Humans [MeSH], Drug Monitoring [MeSH], Emergency Medicine
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37133741
https://repository.publisso.de/resource/frl:6485493 -
15
Autori: a ďalší
Zdroj: Clinical Cancer Research. 24(24)
Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Rare Diseases (rcdc), Clinical Research (rcdc), Pediatric (rcdc), Cancer (rcdc), Patient Safety (rcdc), Clinical Trials and Supportive Activities (rcdc), Neuroblastoma (rcdc), Neurosciences (rcdc), Pediatric Cancer (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Adolescent (mesh), Adult (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Azepines (mesh), Child (mesh), Child, Preschool (mesh), Cohort Studies (mesh), Drug Monitoring (mesh), Drug Resistance, Neoplasm (mesh), Female (mesh), Humans (mesh), Infant (mesh), Irinotecan (mesh), Magnetic Resonance Imaging (mesh), Male (mesh), Neoplasm Recurrence, Local (mesh), Neuroblastoma (mesh), Pyrimidines (mesh), Retreatment (mesh), Temozolomide (mesh), Tomography, X-Ray Computed (mesh), Treatment Outcome (mesh), Young Adult (mesh), Humans (mesh), Neuroblastoma (mesh), Neoplasm Recurrence, Local (mesh), Azepines (mesh), Pyrimidines (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Tomography, X-Ray Computed (mesh), Magnetic Resonance Imaging (mesh), Drug Monitoring (mesh), Treatment Outcome (mesh), Retreatment (mesh), Cohort Studies (mesh), Drug Resistance, Neoplasm (mesh), Adolescent (mesh), Adult (mesh), Child (mesh), Child, Preschool (mesh), Infant (mesh), Female (mesh), Male (mesh), Young Adult (mesh), Irinotecan (mesh), Temozolomide (mesh), Adolescent (mesh), Adult (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Azepines (mesh), Child (mesh), Child, Preschool (mesh), Cohort Studies (mesh), Drug Monitoring (mesh), Drug Resistance, Neoplasm (mesh), Female (mesh), Humans (mesh), Infant (mesh), Irinotecan (mesh), Magnetic Resonance Imaging (mesh), Male (mesh), Neoplasm Recurrence, Local (mesh), Neuroblastoma (mesh), Pyrimidines (mesh), Retreatment (mesh), Temozolomide (mesh), Tomography, X-Ray Computed (mesh), Treatment Outcome (mesh), Young Adult (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3202 Clinical sciences (for-2020), 3211 Oncology and carcinogenesis (for-2020)
Popis súboru: application/pdf
-
16
Autori: a ďalší
Zdroj: Clinical Cancer Research. 24(23)
Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Orphan Drug (rcdc), Clinical Research (rcdc), Lymphatic Research (rcdc), Hematology (rcdc), Lymphoma (rcdc), Cancer (rcdc), Rare Diseases (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Animals (mesh), Antineoplastic Agents (mesh), Bone Marrow (mesh), Clinical Trials as Topic (mesh), DNA Topoisomerases, Type I (mesh), Disease Models, Animal (mesh), Dogs (mesh), Drug Monitoring (mesh), Lymphoma (mesh), Maximum Tolerated Dose (mesh), Molecular Targeted Therapy (mesh), Topoisomerase I Inhibitors (mesh), Bone Marrow (mesh), Animals (mesh), Dogs (mesh), Lymphoma (mesh), Disease Models, Animal (mesh), DNA Topoisomerases, Type I (mesh), Antineoplastic Agents (mesh), Drug Monitoring (mesh), Maximum Tolerated Dose (mesh), Clinical Trials as Topic (mesh), Molecular Targeted Therapy (mesh), Topoisomerase I Inhibitors (mesh), Animals (mesh), Antineoplastic Agents (mesh), Bone Marrow (mesh), Clinical Trials as Topic (mesh), DNA Topoisomerases, Type I (mesh), Disease Models, Animal (mesh), Dogs (mesh), Drug Monitoring (mesh), Lymphoma (mesh), Maximum Tolerated Dose (mesh), Molecular Targeted Therapy (mesh), Topoisomerase I Inhibitors (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3202 Clinical sciences (for-2020), 3211 Oncology and carcinogenesis (for-2020)
Popis súboru: application/pdf
-
17
Autori: a ďalší
Zdroj: Cancer Chemotherapy and Pharmacology. 82(4)
Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Clinical Research (rcdc), Lung (rcdc), Clinical Trials and Supportive Activities (rcdc), Lung Cancer (rcdc), 6.1 Pharmaceuticals (hrcs-rac), 5.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Antineoplastic Agents (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Drug Monitoring (mesh), Female (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Neoplasm Staging (mesh), Neoplasms (mesh), Neutropenia (mesh), Proto-Oncogene Proteins c-met (mesh), Pyrrolidinones (mesh), Quinolines (mesh), Thrombocytopenia (mesh), Topotecan (mesh), Treatment Failure (mesh), Treatment Outcome (mesh), Tivantinib, ARQ-197, Topotecan, MET phosphorylation, Circulating tumor cells, Humans (mesh), Neoplasms (mesh), Thrombocytopenia (mesh), Neutropenia (mesh), Topotecan (mesh), Pyrrolidinones (mesh), Quinolines (mesh), Antineoplastic Agents (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Drug Monitoring (mesh), Neoplasm Staging (mesh), Treatment Outcome (mesh), Treatment Failure (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Proto-Oncogene Proteins c-met (mesh), ARQ-197, Circulating tumor cells, MET phosphorylation, Tivantinib, Topotecan, Antineoplastic Agents (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Drug Monitoring (mesh), Female (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Neoplasm Staging (mesh), Neoplasms (mesh), Neutropenia (mesh), Proto-Oncogene Proteins c-met (mesh), Pyrrolidinones (mesh), Quinolines (mesh), Thrombocytopenia (mesh), Topotecan (mesh), Treatment Failure (mesh), Treatment Outcome (mesh), 1115 Pharmacology and Pharmaceutical Sciences (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020), 3214 Pharmacology and pharmaceutical sciences (for-2020)
Popis súboru: application/pdf
-
18
Autori: a ďalší
Zdroj: PLOS ONE. 13(8)
Predmety: 3207 Medical Microbiology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Infectious Diseases (rcdc), Rare Diseases (rcdc), Infection (hrcs-hc), 3 Good Health and Well Being (sdg), Antimalarials (mesh), Child (mesh), Chromatography, Liquid (mesh), Coinfection (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Lumefantrine (mesh), Malaria (mesh), Pregnancy (mesh), Tandem Mass Spectrometry (mesh), Time Factors (mesh), Humans (mesh), HIV Infections (mesh), Malaria (mesh), Antimalarials (mesh), Drug Monitoring (mesh), Chromatography, Liquid (mesh), Pregnancy (mesh), Time Factors (mesh), Child (mesh), Female (mesh), Tandem Mass Spectrometry (mesh), Coinfection (mesh), Lumefantrine (mesh), Antimalarials (mesh), Child (mesh), Chromatography, Liquid (mesh), Coinfection (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Lumefantrine (mesh), Malaria (mesh), Pregnancy (mesh), Tandem Mass Spectrometry (mesh), Time Factors (mesh), General Science & Technology (science-metrix)
Popis súboru: application/pdf
-
19
Autori: a ďalší
Zdroj: PLOS Medicine. 15(11)
Predmety: 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Prevention (rcdc), Sexually Transmitted Infections (rcdc), HIV/AIDS (rcdc), Patient Safety (rcdc), Clinical Trials and Supportive Activities (rcdc), Clinical Research (rcdc), Women's Health (rcdc), Health Disparities (rcdc), Infectious Diseases (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Infection (hrcs-hc), Adolescent (mesh), Adult (mesh), Aged (mesh), Anti-HIV Agents (mesh), Brazil (mesh), Delayed-Action Preparations (mesh), Double-Blind Method (mesh), Drug Administration Schedule (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Injections, Intramuscular (mesh), Malawi (mesh), Male (mesh), Middle Aged (mesh), Pyridones (mesh), Risk Assessment (mesh), Risk Factors (mesh), South Africa (mesh), Treatment Outcome (mesh), United States (mesh), Young Adult (mesh), Humans (mesh), HIV Infections (mesh), Pyridones (mesh), Delayed-Action Preparations (mesh), Anti-HIV Agents (mesh), Drug Monitoring (mesh), Treatment Outcome (mesh), Injections, Intramuscular (mesh), Drug Administration Schedule (mesh), Risk Assessment (mesh), Risk Factors (mesh), Double-Blind Method (mesh), Adolescent (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Malawi (mesh), South Africa (mesh), United States (mesh), Brazil (mesh), Female (mesh), Male (mesh), Young Adult (mesh), Adolescent (mesh), Adult (mesh), Aged (mesh), Anti-HIV Agents (mesh), Brazil (mesh), Delayed-Action Preparations (mesh), Double-Blind Method (mesh), Drug Administration Schedule (mesh), Drug Monitoring (mesh), Female (mesh), HIV Infections (mesh), Humans (mesh), Injections, Intramuscular (mesh), Malawi (mesh), Male (mesh), Middle Aged (mesh), Pyridones (mesh), Risk Assessment (mesh), Risk Factors (mesh), South Africa (mesh), Treatment Outcome (mesh), United States (mesh), Young Adult (mesh), 11 Medical and Health Sciences (for), General & Internal Medicine (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
Popis súboru: application/pdf
-
20
Autori: a ďalší
Zdroj: Intensive Care Med
Predmety: Adult, Piperacillin, Original, Multiple Organ Failure, Medizin, Penicillanic Acid, Penicillanic Acid [MeSH], Female [MeSH], Anti-Bacterial Agents/therapeutic use [MeSH], Adult [MeSH], β-Lactams, Humans [MeSH], Drug Monitoring [MeSH], Medical and Health Sciences, Multiple Organ Failure [MeSH], Sepsis/drug therapy [MeSH], Sepsis/complications [MeSH], Piperacillin, Tazobactam Drug Combination/therapeutic use [MeSH], Sepsis, Piperacillin/therapeutic use [MeSH], Therapeutic drug monitoring, Anti-Bacterial Agents, 3. Good health, Piperacillin, Tazobactam Drug Combination, Humans, Female, Drug Monitoring
Full Text Finder 
Nájsť tento článok vo Web of Science